Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer (PROTECT)

This study has been completed.
Information provided by (Responsible Party):
Dendreon Identifier:
First received: October 22, 2008
Last updated: October 5, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
No publications provided by Dendreon

Publications automatically indexed to this study by Identifier (NCT Number):